✓ Clinically Reviewed & Verified
Bisodac HF 5mg Bisoprolol Tablets - 1 Strip of 10 Tablets
Managing heart failure and hypertension effectively requires targeted cardiovascular protection. Bisodac HF 5mg provides an essential beta-blocker therapy. It features an active Bisoprolol beta blocker that actively manages severe clinical cardiovascular disorders[cite: 1]. By selectively blocking beta-1 receptors in the heart, it slows the heart rate and reduces the workload on the heart muscle, improving pumping efficiency and protecting against further cardiovascular deterioration.
How to Use / Operate
Take orally exactly as prescribed by your cardiologist. Standardized clinical dosing strictly ensures safe long term circulatory protection[cite: 1]. Swallow the tablet whole with water, ideally in the morning. Do not stop taking this medication abruptly.
Frequently Asked Questions
What is Bisodac HF 5mg used for?
It is a prescription beta-blocker used to treat high blood pressure, prevent angina, and manage chronic heart failure to improve survival rates.
Can I stop taking it suddenly?
No. Stopping Bisoprolol abruptly can cause a dangerous rebound in heart rate and blood pressure. It must be tapered off under medical supervision.
Important Clinical Considerations
As a highly bioavailable compound, it effectively prevents dangerous systemic arterial blood pressure[cite: 1]. However, it should be used with caution in patients with severe asthma or severe chronic obstructive pulmonary disease (COPD), as it can trigger bronchospasms at higher doses. May mask the signs of low blood sugar in diabetics.
| Key Detail |
Value / Specification |
| Active Ingredient |
Bisoprolol Fumarate 5mg |
| Therapeutic Class |
Cardioselective Beta-Blocker |
| Packaging |
1 Strip of 10 Tablets |
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting any new medication or using a medical device. AfyaDepo Pharmacy ensures only authentic, verified products are sourced.
